Skip to content

H2020FP7HORIZON

Novartis Pharma AG

Country
CHSwitzerland
Defence projects
0
Projects, all programmes
85
As coordinator
8
EU contribution (CORDIS)
EUR 2,998,017
Active
2008 to 2025

Projects

85 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
ORBITOOral biopharmaceutics toolsFP72012ParticipantNot stated
OPEN PHACTSThe Open Pharmacological Concepts Triple StoreFP72011ParticipantNot stated
DDMOREDrug Disease Model ResourcesFP72011ParticipantNot stated
EHR4CRElectronic Health Record systems for Clinical ResearchFP72011ParticipantNot stated
RNPNETRNPnet - RNP structure, function and mechanism of actionFP72011ParticipantEUR 244,781
IMIDIAImproving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in diabetesFP72010ParticipantNot stated
SAFESCIMETEuropean Modular Education and Training Programme in Safety Sciences for MedicinesFP72010ParticipantNot stated
MARCARbioMARkers and molecular tumor classification for non-genotoxic CARcinogenesisFP72010CoordinatorNot stated
ENDOSTEMActivation of vasculature associated stem cells and muscle stem cells for the repair and maintenance of muscle tissueFP72010ParticipantEUR 259,100
PHARMA-COGPrediction of cognitive properties of new drug candidates for neurodegenerative diseases in the early clinical developmentFP72010ParticipantNot stated
MEFOPAEuropean Project on Mendelian Forms of Parkinson’s DiseaseFP72010ParticipantEUR 288,000
ETOXIntegrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicitiesFP72010CoordinatorNot stated
PRO- ACTIVEPhysical Activity as a Crucial Patient Reported Outcome in COPDFP72009ParticipantNot stated
U-BIOPREDUnbiased Biomarkers for the Prediction of Respiratory Disease OutcomesFP72009CoordinatorNot stated
EMTRAINEuropean Medicines Research Training NetworkFP72009ParticipantNot stated
NEWMEDSNovel Methods leading to New Medications in Depression and SchizophreniaFP72009ParticipantNot stated
EU2PEuropean programme in Pharmacovigilance and PharmacoepidemiologyFP72009ParticipantNot stated
PHARMATRAINPharmaceutical Medicine Training ProgrammeFP72009ParticipantNot stated
PROTECTPharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTiumFP72009ParticipantNot stated
SAFE-TSAFER AND FASTER EVIDENCE-BASED TRANSLATIONFP72009CoordinatorNot stated

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.